Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 2/20 | 0.50 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.47 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 9/20 | 0.41 |
| ▸ | NPY1R | P25929 | 6/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.41 |
| ▸ | NPY2R | P49146 | 3/20 | 0.41 |
| ▸ | ALB | P02768 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31094973 | 0.96 | GNPAT (0.53) | GNPATSIRT5SIRT6SIRT1FOLH1 | |
| SCHEMBL29655002 | 0.96 | GNPAT (0.53) | GNPATSIRT5SIRT6SIRT1FOLH1 | |
| SCHEMBL29454444 | 0.96 | GNPAT (0.53) | GNPATSIRT5SIRT6SIRT1FOLH1 | |
| SCHEMBL1718474 | 0.96 | GNPAT (0.53) | GNPATSIRT5SIRT6SIRT1FOLH1 | |
| SCHEMBL6026003 | 0.90 | FOLH1 (0.49) | GNPATSIRT5SIRT6SIRT1C3AR1 | |
| SCHEMBL446929 | 0.90 | FOLH1 (0.49) | GNPATSIRT5SIRT6SIRT1C3AR1 | |
| SCHEMBL468901 | 0.90 | FOLH1 (0.49) | GNPATSIRT5SIRT6SIRT1C3AR1 | |
| SCHEMBL30526285 | 0.90 | FOLH1 (0.49) | GNPATSIRT5SIRT6SIRT1C3AR1 | |
| SCHEMBL30248962 | 0.90 | FOLH1 (0.55) | GNPATSIRT5SIRT6SIRT1FOLH1 | |
| SCHEMBL29397145 | 0.90 | SIRT6 (0.56) | GNPATSIRT5SIRT6SIRT1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2198851-B1 | Thickened O/W emulsions | HENKEL AG & CO KGAA (DE) | 2018-03-07 | — | — | EP | disclosed |
| EP-2370177-B1 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO KGAA (DE) | 2017-11-15 | — | — | EP | disclosed |
| EP-1852102-B1 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL AG & CO KGAA (DE) | 2016-10-05 | — | — | EP | disclosed |
| EP-1803435-B1 | Cosmetic sun protection compositions based on lamelliform emulsions | HENKEL AG & CO KGAA (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-2023888-B1 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| WO-2013092080-A1 | PERSONAL HYGIENE COMPOSITION WITH IMPROVED SKIN MOISTURE | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013091975-A1 | BIOMIMETIC COMPOSITIONS FOR SKIN CLEANSING AND SKIN CARE | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
| EP-2097059-B1 | CLEANSING OR CARE PRODUCT | HENKEL KGAA (DE) | 2012-04-18 | — | — | EP | disclosed |
| EP-2370177-A2 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | Henkel AG & Co. KGaA (DE) | 2011-10-05 | — | — | EP | disclosed |
| EP-2266529-A2 | UV protection cosmetic product | Henkel AG & Co. KGaA (DE) | 2010-12-29 | — | — | EP | disclosed |
| EP-1671673-A1 | Pigments containing water-in-siliconoil-emulsion for improving the appearance of the skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2006053688-A1 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT OF MATURE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006042625-A2 | COMPOSITIONS WITH INHIBITORS OF THE SYNTHESIS OF PROSTAGLANDIN AND/OR OF LEUKOTRIENE IN CONJUNCTION WITH STIMULATORS OF THE RELEASE OF CUTANEOUS NEUROMEDIATORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006042627-A2 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES FOR IMPROVING SENSORY PERCEPTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| EP-1634576-A1 | DNA repair enzymes and oligopeptides containing cosmetic and dermatological compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-15 | — | — | EP | disclosed |
| WO-2006018149-A1 | COSMETIC COMPOSITIONS FOR TREATING STRESSED SKIN CONTAINING TAURINE AND LONG-CHAINED FATTY ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006018198-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-6905690-B2 | Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents | EXSYMOL S.A.M. (MC) | 2005-06-14 | — | — | US | disclosed |
| US-20040175397-A1 | Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents | SEGUIN MARIE-CHRISTINE (US) | 2004-09-09 | — | — | US | disclosed |
| US-20030190327-A1 | CITRULLINYLARGININE DIPEPTIDE ANALOGS AND THEIR DERMATOLOGICAL USES AS CARE AND TREATMENT AGENTS | EXSYMOL S.A.M. (MC) | 2003-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040175397-A1 | Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents | ARG1, ARG2, CUTA | GNPAT 2303/4885SIRT5 1987/4885SIRT6 1700/4885 |
| US-20030190327-A1 | CITRULLINYLARGININE DIPEPTIDE ANALOGS AND THEIR DERMATOLOGICAL USES AS CARE AND TREATMENT AGENTS | ARG1, ARG2, ARGLU1 | GNPAT 2635/4885SIRT5 2335/4885SIRT6 1977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.